Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
The blockade of immune checkpoints in cancer immunotherapy
Cancer immunotherapy via dendritic cells
Extracellular vesicles–vehicles that spread cancer genes
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
Immunotherapy using dendritic cells against multiple myeloma: how to improve?
Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Virotherapy of neuroendocrine tumors
Targeting pediatric cancer stem cells with oncolytic virotherapy
Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity
Immunotherapy for metastatic colorectal cancer: present status and new options
Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation